CARE Ratings Issues Q2FY27 Monitoring Agency Report for KIMS Preferential Warrant Issue
Krishna Institute of Medical Sciences Ltd · Others (Uncategorized) · 05 Nov 2026, 2:25 am
CARE Ratings Issues Q2FY27 Monitoring Agency Report for KIMS Preferential Warrant Issue CARE Ratings confirmed zero fund utilization during Q2FY27 from the ₹150 crore upfront warrant subscription money received on 19th Aug'26 out of KIMS's ₹600 crore preferential issue to promoters. The unutilized ₹150 crore is temporarily parked in liquid funds, money market funds, and bank accounts (valued at ₹150.96 crore as of 30th Sep'26). The balance ₹450 crore is receivable upon conversion by 18th Feb'28. CARE flagged conversion risk as KIMS's CMP of ₹730.50 (3rd Nov'26) traded below the warrant exercise price of ₹779.00.
Original exchange filing (PDF)
More announcements from Krishna Institute of Medical Sciences Ltd
- O & M Agreement · 14 Nov 2026
- Transcript of Investor call held on 05.11.2026 · 11 Nov 2026
- Investec Pune Confluence · 10 Nov 2026
- Avendus Spark INDX: Annual Investor Conference · 10 Nov 2026
- Audio Call Link · 06 Nov 2026
- Deviation Report - QIP · 05 Nov 2026
- Deviation Report - Preferential Allotment · 05 Nov 2026
- QIP - Monitoring Agency Report · 05 Nov 2026
